Sabra Health Care REIT (SBRA) FY2019 results: revenue $662 million, up 6.1% on the year
Sabra Health Care REIT, Inc. (SBRA) reported revenue of $662 million for fiscal 2019, the year ended 31 December 2019, up 6.1% on the year before. Net income was $69 million, down 75.3%, and diluted earnings per share $0.37. The figures are the company's own, from the 10-K it filed with the SEC on 24 February 2020.
Revenue
$662 million
+6.1% on the year
FY2012FY2019
Operating margin
n/a
FY2012FY2019
Net income
$69 million
-75.3% on the year
FY2012FY2019
Diluted EPS
$0.37
-75.5% on the year
FY2012FY2019
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Revenue
662
623
408
+6.1%
Interest expense
127
147
88.4
-13.9%
Pre-tax income
79.2
288
159
-72.5%
Income tax
3.4
3.0
0.7
+13.0%
Effective tax rate
4.3%
1.0%
0.4%
Net income
69.0
279
158
-75.3%
Net margin
10.4%
44.8%
38.8%
Diluted EPS
$0.37
$1.51
$1.40
-75.5%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Operating cash flow
372
361
136
+3.3%
Cash from investing
263
-258
-183
Cash from financing
-646
-629
599
Depreciation and amortisation
182
191
114
-5.1%
Share-based compensation
9.8
7.6
8.4
+28.4%
Dividends paid
335
325
182
+3.1%
Dividend per share
$1.80
$1.80
$1.73
0.0%
Diluted shares, weighted
188m
179m
106m
+5.3%
Shares outstanding at period end
205m
178m
178m
+15.1%
Balance sheet
$ million
FY2019
FY2018
FY2017
On the year
Last 8 years
Shareholders' equity
3,488
3,250
3,433
+7.3%
Non-controlling interest
0.0
4.3
4.4
Debt
2,402
3,232
3,394
-25.7%
Other liabilities
179
179
201
+0.1%
Total liabilities and equity
6,069
6,665
7,032
-8.9%
Intangible assets
102
131
167
-22.6%
Loans
63.1
69.5
65.9
-9.2%
Cash and equivalents
39.1
50.2
519
-22.2%
Other assets
5,866
6,415
6,281
-8.6%
Total assets
6,069
6,665
7,032
-8.9%
10-K for the year ended 31 December 2019, filed 24 February 2020: the filing.